HB05389 • 2026

AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE.

Education Healthcare

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Public Health Committee
Last action: 2026-04-15
Official status: Tabled for the Calendar, House
Effective date: Not listed

Plain English Breakdown

The official source material does not provide specific details about the exact content of the toolkit beyond what is required, nor does it specify how feedback will be used in revisions. The bill's effectiveness and impact remain uncertain.

Act to Create a Toolkit for Menopause Care

This act requires the creation and distribution of a toolkit that helps doctors diagnose and treat menopause, perimenopause, and postmenopause.

What This Bill Does

Requires the Department of Public Health to create a toolkit with guidance on diagnosing and treating symptoms related to menopause stages.
Includes input from experts at The University of Connecticut Health Center's Health Disparities Institute and people who have experienced these conditions.
Provides information about hormone treatments, insurance coverage for therapies, and continuing education modules for healthcare providers.
Requires the toolkit to be distributed by June 1, 2028, and revised based on feedback from health care providers.

Who It Names or Affects

Healthcare providers such as doctors, nurses, and other medical professionals who treat patients with menopause symptoms.
Patients experiencing perimenopause, menopause, or postmenopause.

Terms To Know

Menopause: The time when a woman stops having menstrual periods and can no longer become pregnant naturally.
Perimenopause: The period leading up to menopause, during which hormone levels start changing and symptoms begin.
Postmenopause: The time after a woman has not had her menstrual periods for 12 months or more.

Limits and Unknowns

Does not specify the exact content of the toolkit beyond requiring it to cover certain topics.
Does not detail how feedback from healthcare providers will be used in revising the toolkit.
The effectiveness and impact of the toolkit on patient care are unknown.

Bill History

2026-04-15 Connecticut General Assembly
No New File by Committee on Appropriations
2026-04-15 Connecticut General Assembly
Tabled for the Calendar, House
2026-04-14 LCO
Filed with Legislative Commissioners' Office
2026-04-14 LCO
Reported Out of Legislative Commissioners' Office
2026-04-13 APP
Joint Favorable
2026-04-07 Connecticut General Assembly
Referred by House to Committee on Appropriations
2026-03-23 LCO
Reported Out of Legislative Commissioners' Office
2026-03-23 Connecticut General Assembly
Favorable Report, Tabled for the Calendar, House
2026-03-23 Connecticut General Assembly
House Calendar Number 108
2026-03-23 LCO
File Number 114
2026-03-16 LCO
Referred to Office of Legislative Research and Office of Fiscal Analysis 03/23/26 12:00 PM
2026-03-10 LCO
Filed with Legislative Commissioners' Office
2026-03-09 PH
Joint Favorable Substitute
2026-02-27 Connecticut General Assembly
Public Hearing 03/04
2026-02-26 Connecticut General Assembly
Referred to Joint Committee on Public Health

Official Summary Text

To require the development and distribution of a provider toolkit for the diagnosis and treatment of menopause, perimenopause and postmenopause.

Current Bill Text

Read the full stored bill text

LCO 1 of 2

General Assembly Substitute Bill No. 5389
February Session, 2026

AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS
AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND
POSTMENOPAUSE.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:

Section 1. (NEW) (Effective October 1, 2026 ) (a) The Department of 1
Public Health, in consultation with The University of Connecticut 2
Health Center's Health Disparities Institute, persons who have 3
experienced symptoms of perimenopause, menopause and 4
postmenopause, and health care providers who treat persons with 5
symptoms of perimenopause, menopause and postmenopause, shall 6
develop a toolkit that provides practical, evidence-based and culturally 7
appropriate guidance to health care providers in the state who are 8
responsible for diagnosing or treating persons with symptoms of 9
menopause, perimenopause or postmenopause, as determined by the 10
commissioner, including, but not limited to, health care providers in the 11
fields of obstetrics, gynecology, internal medicine, family medicine, 12
emergency medicine, psychiatry, mental health, social work, dentistry, 13
dental hygiene and community health, regarding best practices for 14
screening, identification, clinical assessment, diagnosis and treatment of 15
symptoms of menopause, perimenopause and postmenopause. Such 16
guidance shall include, but need not be limited to, (1) a comprehensive 17
description of the symptoms of menopause, perimenopause and 18
Substitute Bill No. 5389

LCO 2 of 2

postmenopause, (2) evidence -based guidelines regarding the 19
identification and treatment of such symptoms, including, but not 20
limited to, the use of hormones, such as hormone replacement therapy 21
and testosterone therapy, (3) the availability of insurance coverage for 22
such therapies, and (4) short education modules regarding such 23
guidance that would qualify as continuing education for such health 24
care providers. 25
(b) Not later than June 1, 2028, the Commissioner of Public Health 26
shall distribute the toolkit developed pursuant to subsection (a) of this 27
section to such health care providers. Not later than January 1, 2029, the 28
commissioner shall (1) evaluate any feedback received from such health 29
care providers regarding the effectiveness of the toolkit, (2) revise the 30
toolkit as necessary to address such feedback, and (3) distribute a 31
revised toolkit, if any, to such health care providers. 32
This act shall take effect as follows and shall amend the following
sections:

Section 1 October 1, 2026 New section

PH Joint Favorable Subst.
APP Joint Favorable